SNES Q1 2026 Earnings EPS Beat Leaves Room for Guidance Improvements Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline Perdoceo Education Corporation PRDO Q1 2026 Earnings EPS Surpasses Estimates with 5 Surprise Ball Corporation Q1 2026 Earnings EPS Surpasses Estimates with Strong Operational Performance